

Coca-Cola Europacific Partners vs Kimberly-Clark
Major Coca-Cola bottler across Europe and Asia-Pacific vs Global maker of tissue and personal care products. Which is the better buy for your portfolio in September 2026? Plain-English answer below.
Coca-Cola Europacific Partners bottles and distributes Coke products across Western Europe and Australia under a long-term franchise agreement with the Coca-Cola Company, while Kimberly-Clark sells Kleenex, Huggies, and Scott paper products to households around the world. Coca-Cola Europacific Partners vs Kimberly-Clark both generate predictable cash flows from consumer staples brands with deep shelf-space dominance, making them favorites for dividend investors. The analysis examines organic revenue growth, volume trends, cost pass-through ability, and which company delivers stronger earnings per share growth.
Coca-Cola Europacific Partners bottles and distributes Coke products across Western Europe and Australia under a long-term franchise agreement with the Coca-Cola Company, while Kimberly-Clark sells Kl...
Why It’s Moving

CCEP slips as analysts flag limited upside despite steady buyback support
- JPMorgan reiterated an underweight view on CCEP, reinforcing the market’s concern that the stock’s valuation leaves limited room for disappointment.
- Investors are also watching CCEP’s ongoing EUR 1 billion buyback, which supports earnings per share but can’t fully offset worries about near-term upside.
- The latest trading updates show management continuing to repurchase and cancel shares, a sign of confidence in cash generation even as analysts remain cautious.

KMB is drawing attention as investors balance its growth roadmap against fresh signs of near-term pressure.
- Management used the Barclays consumer conference to defend its growth plan, emphasizing innovation, tighter margin control, and portfolio changes even as near-term conditions softened.
- The company flagged slower organic growth, heavier promotions, supply-chain disruptions, and China-related pressure, which helps explain why investors are weighing resilience against short-term earnings strain.
- Recent headlines also pointed to a lowered analyst outlook and mixed institutional trading, reinforcing a cautious tone around the stock despite the company’s steady volume trends and dividend support.

CCEP slips as analysts flag limited upside despite steady buyback support
- JPMorgan reiterated an underweight view on CCEP, reinforcing the market’s concern that the stock’s valuation leaves limited room for disappointment.
- Investors are also watching CCEP’s ongoing EUR 1 billion buyback, which supports earnings per share but can’t fully offset worries about near-term upside.
- The latest trading updates show management continuing to repurchase and cancel shares, a sign of confidence in cash generation even as analysts remain cautious.

KMB is drawing attention as investors balance its growth roadmap against fresh signs of near-term pressure.
- Management used the Barclays consumer conference to defend its growth plan, emphasizing innovation, tighter margin control, and portfolio changes even as near-term conditions softened.
- The company flagged slower organic growth, heavier promotions, supply-chain disruptions, and China-related pressure, which helps explain why investors are weighing resilience against short-term earnings strain.
- Recent headlines also pointed to a lowered analyst outlook and mixed institutional trading, reinforcing a cautious tone around the stock despite the company’s steady volume trends and dividend support.
Investment Analysis
Pros
- Reported solid Q3 2025 revenue growth of 1.0%, driven by volume growth and higher revenue per unit case.
- Continues to increase market share ahead of competition within its territories.
- Receives mostly positive analyst sentiment, with an average price target indicating upside potential near 9-19%.
Considerations
- Modest volume growth at only 0.4% in Q3 suggests limited near-term expansion in core beverage sales.
- Analyst opinions are mixed, with some Hold and Sell ratings alongside Buy recommendations, reflecting some uncertainty.
- Short selling activity remains notable at 8.88%, indicating some investor bearishness or hedging.
Pros
- Kimberly-Clark's price-to-earnings ratio of 16.27 is below its 3-, 5-, and 10-year averages, potentially indicating value relative to its history.
- Market capitalization around $31 billion reflects its status as a leading global consumer goods company.
- Maintains steady financial metrics amid competitive pressure in personal care and household products.
Considerations
- Current PE ratio below historical averages may partly reflect slower growth or margin pressure concerns.
- Faces industry-wide challenges including inflationary cost pressures and evolving consumer preferences.
- Competitive dynamics could impact pricing power and margin sustainability in key product categories.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
CCEP’s next earnings date is typically expected around November 4–6, 2026, based on its historical reporting pattern. The upcoming report should cover Q3 2026. If the company confirms a specific release date, it is usually announced closer to the earnings window.
Kimberly-Clark (KMB) Next Earnings Date
Kimberly-Clark’s next earnings date is expected to be October 29, 2026. The report should cover third-quarter 2026 results. This date is an estimated release based on the company’s typical reporting pattern and has not been formally confirmed.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
CCEP’s next earnings date is typically expected around November 4–6, 2026, based on its historical reporting pattern. The upcoming report should cover Q3 2026. If the company confirms a specific release date, it is usually announced closer to the earnings window.
Kimberly-Clark (KMB) Next Earnings Date
Kimberly-Clark’s next earnings date is expected to be October 29, 2026. The report should cover third-quarter 2026 results. This date is an estimated release based on the company’s typical reporting pattern and has not been formally confirmed.
Buy CCEP or KMB in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


